Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma

BACKGROUND Treatment options are limited for patients with advanced acquired immunodeficieny syndrome (AIDS)‐related Kaposi sarcoma (AIDS‐KS) whose disease has progressed after receiving therapy with liposomal anthracyclines or combination chemotherapy with doxorubicin (Adriamycin), bleomycin, and v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2002-07, Vol.95 (1), p.147-154
Hauptverfasser:	Tulpule, Anil, Groopman, Jerome, Saville, M. Wayne, Harrington, William, Friedman‐Kien, Alvin, Espina, Byron M., Garces, Carlos, Mantelle, Lily, Mettinger, Karl, Scadden, David T., Gill, Parkash S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - complications Adult AIDS Antineoplastic agents Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Chemotherapy Female Humans Kaposi sarcoma Male Medical sciences Middle Aged paclitaxel Paclitaxel - adverse effects Paclitaxel - therapeutic use Paxene Pharmacology. Drug treatments Protease Inhibitors - therapeutic use Quality of Life Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - mortality Sarcoma, Kaposi - psychology Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!